Tag: moderna

Moderna, Inc. recently hosted a highly anticipated conference call to discuss groundbreaking Phase III clinical data for its investigational cancer immunotherapy, intismeran, while outlining broader advancements in the rapidly evolving field of oncology. The presentation, held on October 24, 2026, brought together key company executives, lead clinical investigators, and world-renowned experts in melanoma and cancer…